The American Journal of Gastroenterology · 2019 · 1.5K citations · 186 references
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines recommend the preferred management of adults with UC and constitute the official practice recommendations of the American College of Gastroenterology. The guidelines were developed by evaluating evidence with the GRADE process and, where GRADE was unsuitable, by expert consensus to produce key concept statements. The guidelines are broadly applicable and represent the preferred, though not exclusive, approach to clinical scenarios.
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process. In instances where the evidence was not appropriate for GRADE, but there was consensus of significant clinical merit, “key concept” statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not only, approach to clinical scenarios.
186
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.8K citations · Full text
Mark S. Silverberg, Jack Satsangi, Tariq Ahmad et al. · Canadian Journal of Gastroenterology · 2005 · 3.3K citations · Full text
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text